DK0533209T3 - Farmaceutisk præparat indeholdende protein C som beta-sympatomimetikum. - Google Patents

Farmaceutisk præparat indeholdende protein C som beta-sympatomimetikum.

Info

Publication number
DK0533209T3
DK0533209T3 DK92117248.2T DK92117248T DK0533209T3 DK 0533209 T3 DK0533209 T3 DK 0533209T3 DK 92117248 T DK92117248 T DK 92117248T DK 0533209 T3 DK0533209 T3 DK 0533209T3
Authority
DK
Denmark
Prior art keywords
beta
sympathomimetic
pharmaceutical preparation
preparation containing
containing protein
Prior art date
Application number
DK92117248.2T
Other languages
English (en)
Inventor
Johann Dr Eibl
Ludwig Prof Dr Pichler
Hans-Peter Doz Dr Schwarz
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Application granted granted Critical
Publication of DK0533209T3 publication Critical patent/DK0533209T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK92117248.2T 1990-08-16 1991-01-28 Farmaceutisk præparat indeholdende protein C som beta-sympatomimetikum. DK0533209T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0169790A AT402260B (de) 1990-08-16 1990-08-16 Protein c-hältige pharmazeutische präparation

Publications (1)

Publication Number Publication Date
DK0533209T3 true DK0533209T3 (da) 1997-09-22

Family

ID=3519039

Family Applications (3)

Application Number Title Priority Date Filing Date
DK92117248.2T DK0533209T3 (da) 1990-08-16 1991-01-28 Farmaceutisk præparat indeholdende protein C som beta-sympatomimetikum.
DK91890012.7T DK0471660T3 (da) 1990-08-16 1991-01-28 Protein C til behandling af smerte
DK92117249.0T DK0533210T3 (da) 1990-08-16 1991-01-28 Protein C-holdige farmaceutiske præparater som midler mod inflammation.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK91890012.7T DK0471660T3 (da) 1990-08-16 1991-01-28 Protein C til behandling af smerte
DK92117249.0T DK0533210T3 (da) 1990-08-16 1991-01-28 Protein C-holdige farmaceutiske præparater som midler mod inflammation.

Country Status (12)

Country Link
EP (3) EP0533209B1 (da)
JP (1) JP2530770B2 (da)
AT (6) AT402260B (da)
CA (1) CA2041380C (da)
CZ (1) CZ280004B6 (da)
DE (3) DE59108638D1 (da)
DK (3) DK0533209T3 (da)
ES (3) ES2103861T3 (da)
HR (1) HRP921237A2 (da)
HU (1) HUT60147A (da)
RU (1) RU2066550C1 (da)
YU (1) YU77591A (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571786A (en) * 1990-08-16 1996-11-05 Immuno Aktiengesellschaft Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation
AT397615B (de) * 1991-05-14 1994-05-25 Immuno Ag Arzneimittel enthaltend protein c
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
EP0733371B1 (de) * 1995-03-21 2002-06-19 Baxter Aktiengesellschaft Mittel zur subkutanen Verabreichung von Protein C
DE19608218A1 (de) * 1995-03-21 1996-09-26 Immuno Ag Mittel zur subkutanen Verabreichung von Protein C
WO2006072137A1 (en) * 2005-01-07 2006-07-13 Northern Sydney And Central Coast Area Health Service Treatment for autoimmune and inflammatory conditions
CA2877745C (en) * 2012-07-04 2021-11-30 The University Of Sydney Treatment of inflammatory skin disorders
ES2890675T3 (es) 2014-04-16 2022-01-21 Zz Biotech Llc APC para uso en el tratamiento de cicatrices cutáneas anormales

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2739050B2 (ja) * 1988-01-28 1998-04-08 ヘキスト薬品工業株式会社 抗血液凝固剤
US5093117A (en) * 1989-01-24 1992-03-03 Baxter International Inc. Compositions and method for the treatment or prophylaxis of sepsis or septic shock

Also Published As

Publication number Publication date
JPH04230633A (ja) 1992-08-19
DK0471660T3 (da) 1995-12-18
HUT60147A (en) 1992-08-28
EP0471660A2 (de) 1992-02-19
ATE126699T1 (de) 1995-09-15
EP0471660B1 (de) 1995-08-23
RU2066550C1 (ru) 1996-09-20
DE59108697D1 (de) 1997-06-05
ATA20492A (de) 1997-10-15
AT403439B (de) 1998-02-25
ATA169790A (de) 1996-08-15
EP0533209B1 (de) 1997-03-26
ES2080289T3 (es) 1996-02-01
ATA20392A (de) 1997-07-15
CA2041380C (en) 1997-10-07
ATE150649T1 (de) 1997-04-15
AT402260B (de) 1997-03-25
JP2530770B2 (ja) 1996-09-04
DE59106292D1 (de) 1995-09-28
HRP921237A2 (en) 1995-10-31
ATE152354T1 (de) 1997-05-15
DE59108638D1 (de) 1997-04-30
EP0533209A1 (de) 1993-03-24
ES2102435T3 (es) 1997-08-01
ES2103861T3 (es) 1997-10-01
CS121391A3 (en) 1992-02-19
EP0533210B1 (de) 1997-05-02
EP0471660A3 (en) 1992-04-15
CZ280004B6 (cs) 1995-09-13
DK0533210T3 (da) 1997-11-03
CA2041380A1 (en) 1992-02-17
EP0533210A1 (de) 1993-03-24
AT403763B (de) 1998-05-25
YU77591A (sh) 1995-10-24
HU911348D0 (en) 1991-10-28

Similar Documents

Publication Publication Date Title
LV10434A (lv) 3-Amidopirazola atvasinajumi to iegusanas panemiens un farmaceitiskais sastavs uz to bazes
PT87455A (pt) Process for the preparation of tampon applicators and applicat ors made by said process
NO171344C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator
DK0533209T3 (da) Farmaceutisk præparat indeholdende protein C som beta-sympatomimetikum.
KR900701323A (ko) 신규한 녹내장 치료용 안과 제제
ES2054098T3 (es) Uso de minoxidilo para la curacion de heridas.
AR004691A1 (es) Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion
NO843381L (no) Analogifremgangsmaate for fremstilling av peptid
DE3875349D1 (de) Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie.
DK311484D0 (da) Vandoploeselige rifampicinderivater og fremgangsmaade til fremstilling deraf
DE3751597D1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel.
IT1151104B (it) Impiego terapeutico di derivati (1-cinnamoil oppure 1-fenetil-carbonil)piperazinici
FI934468A0 (fi) Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytesmellanprodukter
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
IT1215590B (it) Derivati della 1-benzene solfonil 2-oco 5-alchiltio pirrolidina, un loro procedimentodi preparazione e il loro impiegocome stostanze medicinali.
FI924088A0 (fi) Anvaendning av prostaglandin f3a som oegontryck saenkande medel.
IT1169978B (it) Preparato per la cura delle ustioni
NO931914D0 (no) Anvendelse av halogenimider som brannhemmende midler
IT1190755B (it) Procedimento per la preparazione di derivati di 2-dietilamino-1-metiletil cis-1-idrossi-(bicicloesil)-2-carbossilato
DK163865C (da) Anvendelse af oestrogener til fremstilling af praeparater til lokal anvendelse til behandling af forhoejet tryk i oejet
KR890007167U (ko) 펌프용 소형 압축탱크의 가스밸브
SE9202013D0 (sv) Saett foer beredning av loesning foer medicinsk anvaendning
NO923642D0 (no) Anvendelse av 5-trans-prostaglandin f2alfa som et okulart hypotensivt middel
CS942287A1 (en) Tester of high-pressure sodium vapour lamps' thyristor starters
SE8605216D0 (sv) Novel medicinal use